Enalapril Maleate/Diltiazem Malate

马来酸依那普利/苹果酸地尔硫卓

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEnalapril Maleate/Diltiazem Malate
Drug Alias Name苹果酸地尔硫卓+马来酸依那普利Cardizem LA+VasotecDiltiazem Malate+Enalapril MaleateTeczem
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsVoltage-dependent calcium channel gamma-1 subunit blockers
TargetsVoltage-dependent calcium channel gamma-1 subunitAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/10/04
Country/TerritoryUnited States
CombinationsYes Enalapril MaleateDiltiazem Malate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBiovail Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiovail (Uk) Ltd
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A